|Articles|December 8, 2011
Video blog: BOLERO-2 and Afinitor in breast cancer
Author(s)Debu Tripathy
Advertisement
Dr. Debu Tripathy explains the updated results of the BOLERO-2 study, which looked at Afinitor (everolimus) and an aromatase inhibitor in metastatic breast cancer. How useful will this new drug be in metastatic breast cancer?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Trodelvy Plus Keytruda Shows Lasting Benefit in Metastatic Breast Cancer
2
Oncologist Answers Most Asked Questions About Colorectal Cancer
3
Nurse-Led Quality Initiative Reduces CLABSI Risk in Hematologic Cancer Care
4
The Most Asked Bladder Cancer Questions: Signs, Symptoms, Stages and Treatment Options
5